VICP — Vicapsys Life Sciences, Inc.

OTC · Health Care · Pharmaceuticals · CIK 1468639 ·
Last close
$1.46
Market Cap
$47.26M
52W High
$1.50
52W Low
$0.15
ADV30
0
Next earnings
Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Sep 2024 0 -198,862 -235,507 89,569 89,569 2,735,296

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-40,431
Investing CF
Financing CF
$130,000
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.01
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-17,052,745
Inventory
Receivables
ST Investments
EBIT TTM
$-198,862
Pretax Income TTM
$-235,507
Interest Exp TTM
$36,645
Analysts

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2023 0 -1,046,978 -1,182,112 39,656 1,968,337 -417,524
Dec 2022 0 -644,559 -984,790 72,021 1,022,812 -238,197

Peers — same industry

TickerNameMarket CapLastDaily %
ETST Earth Science Tech, Inc. $48.95M $0.17
INCR Intercure Ltd. $49.51M $0.91
QNTM Quantum Biopharma Ltd. $45.11M $7.05
XLO Xilio Therapeutics, Inc. $49.96M $8.35
PYRGF PyroGenesis Canada Inc. $44.26M $0.21

Recent Insider Activity

No insider activity indexed for this ticker.